Varex Imaging Corporation (VREX)

Varex Imaging Corp. stock has trended upwards by 59.31% in the past six months. As of December 29, 2025, the share price was $11.88, a 17.61% decline over the past year. Recent events include the upcoming Annual General Meeting on February 12, 2026, and the President exercising options and selling stock. Consensus EPS estimates were upgraded to a US$0.46 loss. Options traders anticipate a significant price movement for Varex Imaging shares, and one analyst has revised the earnings estimate downward for the current quarter.

Varex Imaging's revenue streams are diversified across medical imaging and industrial applications. The medical segment sees predictable revenue from X-ray tube replacements, while the industrial segment has shown strong growth in cargo systems. Sales in China improved in Q1 FY2025. Photon Counting Detectors are projected to contribute significantly to revenue by 2029. Management remains cautious about macroeconomic uncertainties and potential changes in tariffs.

Varex Imaging Corp., based in Salt Lake City, Utah, is a leading innovator, designer, and manufacturer of X-ray imaging components and software within the Health Technology sector. The company provides X-ray imaging components to OEMs, independent service companies, and end-users. Varex's product portfolio includes X-ray tubes, digital detectors, and other imaging components and solutions used in medical, security, and industrial applications.

Varex Imaging Corp. has a global presence with manufacturing facilities in the US, the Netherlands, the UK, China, India, Germany, Finland, and the Philippines. The company operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific. A new operational launch in India is planned by the end of fiscal year 2025 to manage costs, mitigate supply chain risks, and position the company for regional growth.

Varex Imaging Corporation has a long history of innovation in X-ray technology and is recognized as a leading independent supplier of X-ray components and image processing solutions. The company's mission is to deliver innovative solutions that enhance diagnostic accuracy and patient care worldwide. Varex has solidified its reputation through strategic initiatives and product launches, with a significant portion of its revenue stemming from its OEM channel. Analyst sentiment towards Varex Imaging is predominantly positive.

Institutional investors are the primary owners of Varex Imaging, holding a substantial majority of the company's stock. As of May 2025, institutional investors held 96.34% of the shares, while insiders held 1.41%. Major institutional owners include Pzena Investment Management, Inc./LLC, BlackRock, Inc., and The Vanguard Group, Inc. Richard Pzena is a prominent individual holder, owning 9.16% of the company's holdings.